Clariane SE (CLARI.PA)
EUR 3.78
(0.11%)
EUR 3.78
(0.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 11.24 Billion EUR | 5.02% |
| 2022 | 10.7 Billion EUR | 1.54% |
| 2021 | 10.54 Billion EUR | 6.77% |
| 2020 | 9.87 Billion EUR | 18.0% |
| 2019 | 8.36 Billion EUR | 65.54% |
| 2018 | 5.05 Billion EUR | 8.95% |
| 2017 | 4.64 Billion EUR | 4.11% |
| 2016 | 4.45 Billion EUR | 16.34% |
| 2015 | 3.83 Billion EUR | 14.28% |
| 2014 | 3.35 Billion EUR | 116.52% |
| 2013 | 1.54 Billion EUR | 3.28% |
| 2012 | 1.49 Billion EUR | 9.73% |
| 2011 | 1.36 Billion EUR | 16.12% |
| 2010 | 1.17 Billion EUR | 4.95% |
| 2009 | 1.12 Billion EUR | 3.25% |
| 2008 | 1.08 Billion EUR | 5.03% |
| 2007 | 1.03 Billion EUR | 66.92% |
| 2006 | 619.34 Million EUR | -17.92% |
| 2005 | 754.57 Million EUR | 94.99% |
| 2004 | 386.98 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 10.75 Billion EUR | -0.0% |
| 2024 Q1 | 10.75 Billion EUR | -4.32% |
| 2023 FY | 11.24 Billion EUR | 5.02% |
| 2023 Q3 | 11.24 Billion EUR | 3.17% |
| 2023 Q4 | 11.24 Billion EUR | 0.0% |
| 2023 Q2 | 10.89 Billion EUR | 0.0% |
| 2023 Q1 | 10.89 Billion EUR | 1.79% |
| 2022 Q3 | 10.7 Billion EUR | 1.35% |
| 2022 Q2 | 10.56 Billion EUR | 0.0% |
| 2022 FY | 10.7 Billion EUR | 1.54% |
| 2022 Q1 | 10.56 Billion EUR | 0.19% |
| 2022 Q4 | 10.7 Billion EUR | 0.0% |
| 2021 FY | 10.54 Billion EUR | 6.77% |
| 2021 Q4 | 10.54 Billion EUR | 0.0% |
| 2021 Q1 | 10.13 Billion EUR | 2.6% |
| 2021 Q2 | 10.13 Billion EUR | 0.0% |
| 2021 Q3 | 10.54 Billion EUR | 4.07% |
| 2020 Q3 | 9.87 Billion EUR | 6.59% |
| 2020 Q1 | 9.26 Billion EUR | 10.7% |
| 2020 FY | 9.87 Billion EUR | 18.0% |
| 2020 Q2 | 9.26 Billion EUR | 0.0% |
| 2020 Q4 | 9.87 Billion EUR | 0.0% |
| 2019 Q4 | 8.36 Billion EUR | 0.0% |
| 2019 Q1 | 8.23 Billion EUR | 62.82% |
| 2019 FY | 8.36 Billion EUR | 65.54% |
| 2019 Q2 | 8.23 Billion EUR | 0.0% |
| 2019 Q3 | 8.36 Billion EUR | 1.67% |
| 2018 Q3 | 5.05 Billion EUR | 5.35% |
| 2018 Q4 | 5.05 Billion EUR | 0.0% |
| 2018 FY | 5.05 Billion EUR | 8.95% |
| 2018 Q2 | 4.79 Billion EUR | 0.0% |
| 2018 Q1 | 4.79 Billion EUR | 3.42% |
| 2017 FY | 4.64 Billion EUR | 4.11% |
| 2017 Q4 | 4.64 Billion EUR | 0.0% |
| 2017 Q3 | 4.64 Billion EUR | 1.09% |
| 2017 Q2 | 4.59 Billion EUR | 0.0% |
| 2017 Q1 | 4.59 Billion EUR | 2.98% |
| 2016 Q2 | 4.38 Billion EUR | 0.0% |
| 2016 FY | 4.45 Billion EUR | 16.34% |
| 2016 Q4 | 4.45 Billion EUR | 0.0% |
| 2016 Q3 | 4.45 Billion EUR | 1.74% |
| 2016 Q1 | 4.38 Billion EUR | 14.35% |
| 2015 FY | 3.83 Billion EUR | 14.28% |
| 2015 Q4 | 3.83 Billion EUR | 0.0% |
| 2015 Q1 | 3.4 Billion EUR | 1.7% |
| 2015 Q2 | 3.4 Billion EUR | 0.0% |
| 2015 Q3 | 3.83 Billion EUR | 12.37% |
| 2014 Q2 | 2.76 Billion EUR | 0.0% |
| 2014 FY | 3.35 Billion EUR | 116.52% |
| 2014 Q4 | 3.35 Billion EUR | 0.0% |
| 2014 Q3 | 3.35 Billion EUR | 21.15% |
| 2014 Q1 | 2.76 Billion EUR | 78.72% |
| 2013 Q4 | 1.54 Billion EUR | 0.0% |
| 2013 FY | 1.54 Billion EUR | 3.28% |
| 2013 Q1 | 1.6 Billion EUR | 7.38% |
| 2013 Q2 | 1.6 Billion EUR | 0.0% |
| 2013 Q3 | 1.54 Billion EUR | -3.82% |
| 2012 Q2 | 1.41 Billion EUR | 0.0% |
| 2012 Q4 | 1.49 Billion EUR | 0.0% |
| 2012 FY | 1.49 Billion EUR | 9.73% |
| 2011 FY | 1.36 Billion EUR | 16.12% |
| 2011 Q2 | 1.24 Billion EUR | 0.0% |
| 2011 Q4 | 1.36 Billion EUR | 0.0% |
| 2010 FY | 1.17 Billion EUR | 4.95% |
| 2010 Q2 | 1.17 Billion EUR | 0.0% |
| 2010 Q4 | 1.17 Billion EUR | 0.0% |
| 2009 Q4 | 1.12 Billion EUR | 0.0% |
| 2009 FY | 1.12 Billion EUR | 3.25% |
| 2008 FY | 1.08 Billion EUR | 5.03% |
| 2007 FY | 1.03 Billion EUR | 66.92% |
| 2006 FY | 619.34 Million EUR | -17.92% |
| 2005 FY | 754.57 Million EUR | 94.99% |
| 2004 FY | 386.98 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ramsay Générale de Santé SA | 5.66 Billion EUR | -98.455% |
| LNA Santé SA | 1.19 Billion EUR | -838.033% |